Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Sat Dec 16 19:12:34 GMT 2023
by
admin
on
Sat Dec 16 19:12:34 GMT 2023
|
Protein Type | PEPTIDE |
Protein Sub Type | T-CELL ANTIGEN |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
28GAR3B45E
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
906922
Created by
admin on Sat Dec 16 19:12:35 GMT 2023 , Edited by admin on Sat Dec 16 19:12:35 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
1609460-62-9
Created by
admin on Sat Dec 16 19:12:35 GMT 2023 , Edited by admin on Sat Dec 16 19:12:35 GMT 2023
|
PRIMARY | |||
|
28GAR3B45E
Created by
admin on Sat Dec 16 19:12:35 GMT 2023 , Edited by admin on Sat Dec 16 19:12:35 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->ANTIGEN |
Attempts to induce tolerance to Factor VIII to prevent or eliminate the formation of antibodies in patients receiving Factor VIII
|
||
|
TARGET->TOLEROGEN |
Attempts to induce tolerance to Factor VIII to prevent or eliminate the formation of antibodies in patients receiving Factor VIII
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Attempts to induce tolerance to Factor VIII to prevent or eliminate the formation of antibodies in patients receiving Factor VIII
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|
||||
Molecular Formula | CHEMICAL |
|